BIOREGENX, INC. — Income Charts
2 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$2M
Cost of Revenue
$351K
Gross Profit
$2M
R&D
$32K
SG&A
$2M
D&A
$75K
Operating Income
$-1M
EBITDA
$-1M
Interest Expense
$300K
Other Income/Expense
—
Pretax Income
—
Tax Provision
$0
Net Income
$-2M
Gross Margin
81.1%
Operating Margin
-67.1%
Net Margin
-83.2%
Effective Tax Rate
—
Deferred Tax Assets
$0
DTA Valuation Allowance
$2M
NOL Carryforwards
$6M
ETR (Continuing Operations)
0.0%
ETR Federal Statutory
21.0%
ETR State + Local (pp)
-4.4%
Operating Lease Cost
$21K
Revenue YoY Variation
-20.8%
Income YoY Variation
94.5%